HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.

Abstract
Hypoxia-inducible factor (HIF) deregulation contributes to the Warburg effect. HIF consists of an unstable α subunit and a stable β subunit. In the presence of oxygen, HIFα becomes prolyl hydroxylated by members of the EglN (also called PHD) family, leading to its proteasomal degradation. Under hypoxic conditions, EglN activity is diminished and HIF levels rise. EglN1 is the primary HIF prolyl hydroxylase with EglN2 and EglN3 playing compensatory roles under certain conditions. EglN2 and EglN3 also appear to play HIF-independent roles in regulating cell proliferation and apoptosis, respectively. The EglNs belong to a large family of 2-oxoglutarate-dependent dioxygenases that includes the TET DNA hydroxymethylases and JmjC-containing histone demethylases. Members of this superfamily can be inhibited by endogenous metabolites, including fumarate and succinate, which accumulate in tumors that have fumarate hydratase (FH) or succinate dehydrogenase (SDH) mutations, respectively, as well as by the 2-hydroxyglutarate detected in isocitrate dehydrogenase (IDH) mutant tumors. 2-Oxoglutarate-dependent dioxygenases therefore provide a link between altered metabolism and cancer.
AuthorsW G Kaelin Jr
JournalCold Spring Harbor symposia on quantitative biology (Cold Spring Harb Symp Quant Biol) Vol. 76 Pg. 335-45 ( 2011) ISSN: 1943-4456 [Electronic] United States
PMID22089927 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Basic Helix-Loop-Helix Transcription Factors
  • Ketoglutaric Acids
  • endothelial PAS domain-containing protein 1
  • Dioxygenases
Topics
  • Animals
  • Basic Helix-Loop-Helix Transcription Factors (metabolism)
  • Dioxygenases (antagonists & inhibitors, metabolism)
  • Glycolysis
  • Humans
  • Ketoglutaric Acids (metabolism)
  • Molecular Targeted Therapy
  • Neoplasms (enzymology, metabolism, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: